Search

Your search keyword '"Fraietta, J."' showing total 1 results
Start Over Author "Fraietta, J." Topic t cells
1 results on '"Fraietta, J."'

1. FOURTH GENERATION HUCART19‐IL18 PRODUCES DURABLE RESPONSES IN LYMPHOMA PATIENTS PREVIOUSLY RELAPSED/REFRACTORY TO ANTI‐CD19 CAR T‐CELL THERAPY.

Author

Svoboda, J., Landsburg, D. L., Chong, E. A., Barta, S. K., Nasta, S. D., Ruella, M., Hexner, E. O., Marshall, A., Leskowitz, R., Four, M., Shea, J., Cervini, A., Davis, M. M., Please, G., Hasenmayer, D., Amortegui, J. R., Hwang, W., Frey, N., Siegel, D. L., and Fraietta, J.

Subjects
DISEASE relapse, T cells, LYMPHOMAS
Abstract

FOURTH GENERATION HUCART19-IL18 PRODUCES DURABLE RESPONSES IN LYMPHOMA PATIENTS PREVIOUSLY RELAPSED/REFRACTORY TO ANTI-CD19 CAR T-CELL THERAPY B Introduction: b Lymphoma (NHL) patients (pts) relapsing/refractory (R/R) to anti-CD19 chimeric antigen receptor T-cells (CART) represent a challenging group in need of effective therapies. B Conclusions: b HuCART19-IL18 therapy results in durable responses in pts with CD19+ NHL who are R/R to prior 2 SP nd sp generation anti-CD19 CART. [Extracted from the article]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results